Open AccessSARS ‐CoV‐2, bacterial co‐infections, and AMR : the deadly trio in COVID ‐19?
Author(s) -
Bengoechea Jose A,
Bamford Connor GG
Publication year - 2020
Publication title -
embo molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.923
H-Index - 107
eISSN - 1757-4684
pISSN - 1757-4676
DOI - 10.15252/emmm.202012560
Subject(s) - covid-19 , microbiology and biotechnology , virology , antimicrobial , respiratory system , betacoronavirus , medicine , immunology , biology , infectious disease (medical specialty) , disease , pathology , outbreak
Respiratory viral infections are well known to predispose patients to bacterial co‐infections and superinfections. Still, there is limited reference to these in COVID ‐19. Do co‐infections play a significant role during COVID ‐19? What is the impact of antimicrobial resistance?